Front Neurol. 2022 Jun 28;13:900582. doi: 10.3389/fneur.2022.900582. eCollection 2022. PMID: 35837230
Conclusion: Screening for atrial fibrillation scale (SAFE) is a novel and simple strategy for selecting ischemic stroke patients at higher risk of having AF who can benefit from a
more thorough etiological evaluation. External validation of SAFE in a multicenter study, with a larger number of patients, is warranted.
more thorough etiological evaluation. External validation of SAFE in a multicenter study, with a larger number of patients, is warranted.
FUNDING: The investigators were granted funds by the Carlos III Institute of Health (RICORS-ICTUS and RD21/0006/0010).